BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15579288)

  • 1. Identification of potential antibody markers in HIV-associated dementia.
    Schutzer SE; Berger JR; Brunner M
    J Neuroimmunol; 2004 Dec; 157(1-2):120-5. PubMed ID: 15579288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid western Blot profiles in the evolution of HIV-1 pediatric encephalopathy.
    Ruţă SM; Mătuşa R; Cernescu CC
    Rom J Virol; 1998; 49(1-4):61-71. PubMed ID: 10892427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha tumor necrosis factor in central nervous system disease associated with HIV infection].
    Calvo Manuel E; Arranz Garcia F; Sánchez-Portocarrero J; Roca Arbones V; Puente M; Elias Arcalis A; Pérez-Cecilia E; Nieto Sánchez A; Espinos Pérez D
    An Med Interna; 1995 Jun; 12(6):263-6. PubMed ID: 7548640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of CSF glial fibrillary acidic protein (GFAP) as a putative marker for HIV-associated dementia.
    Sporer B; Missler U; Magerkurth O; Koedel U; Wiesmann M; Pfister HW
    Infection; 2004 Feb; 32(1):20-3. PubMed ID: 15007738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal reactivity for myelin components precedes development of neurological symptoms in AIDS patients.
    Silva AA; Câmara V; Quirico-Santos T
    Arch Med Res; 1997; 28(3):391-6. PubMed ID: 9291637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune markers in HIV-associated dementia.
    Schutzer SE; Brunner M; Fillit HM; Berger JR
    J Neuroimmunol; 2003 May; 138(1-2):156-61. PubMed ID: 12742665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.
    Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR
    Brain Behav Immun; 1995 Dec; 9(4):366-77. PubMed ID: 8903853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroophthalmological examination in children with AIDS.
    Constantinescu AF; Ruţă SM; Constantinescu SN; Cernescu C
    Rev Roum Virol; 1993; 44(3-4):187-93. PubMed ID: 7826869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.
    Brew BJ; Pemberton L; Blennow K; Wallin A; Hagberg L
    Neurology; 2005 Nov; 65(9):1490-2. PubMed ID: 16275845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.
    Price RW; Brew BJ; Rosenblum M
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():269-90. PubMed ID: 2183316
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement.
    Lazzarin A; Castagna A; Cavalli G; Amprimo MC; Vaj M; Parravicini CL; Costanzi G; Ronchi P; Foppa CU; Moroni M; Turconi R
    J Clin Lab Immunol; 1992; 38(4):175-86. PubMed ID: 11270518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders.
    Abbate I; Cappiello G; Longo R; Ursitti A; Spanò A; Calcaterra S; Dianzani F; Antinori A; Capobianchi MR
    Infect Genet Evol; 2005 Apr; 5(3):247-53. PubMed ID: 15737916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
    Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
    Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
    Gisslen M; Hagberg L; Brew BJ; Cinque P; Price RW; Rosengren L
    J Infect Dis; 2007 Jun; 195(12):1774-8. PubMed ID: 17492593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of brain magnetic resonance studies in the diagnostics of central nervous system lesions in HIV-1 positive patients].
    Sokolska V; Knysz B; Czapiga E; Gasiorowski J; Sasiadek M; Gładysz A
    Wiad Lek; 2006; 59(11-12):805-13. PubMed ID: 17427496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an update.
    Cinque P; Bossolasco S; Bestetti A; Sala S; Pierotti C; Lazzarin A
    J Neurovirol; 2002 Dec; 8 Suppl 2():122-8. PubMed ID: 12491163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 associated dementia: symptoms and causes.
    Ghafouri M; Amini S; Khalili K; Sawaya BE
    Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients.
    Sporer B; Koedel U; Popp B; Paul R; Pfister HW
    J Neuroimmunol; 2005 Jun; 163(1-2):190-4. PubMed ID: 15885322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS of the nervous system--a new infectious disease of the immune system of the brain (review)].
    Malashkhiia IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(6):122-7. PubMed ID: 1664569
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dementia complex due to HIV disease and aging].
    Moulignier A
    Psychol Neuropsychiatr Vieil; 2007 Sep; 5(3):193-207. PubMed ID: 17872328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.